NASDAQ:ICU SeaStar Medical (ICU) Stock Price, News & Analysis $0.64 +0.07 (+12.07%) As of 03:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About SeaStar Medical Stock (NASDAQ:ICU) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SeaStar Medical alerts:Sign Up Key Stats Today's Range$0.56▼$0.6750-Day Range$0.55▼$1.2452-Week Range$0.31▼$4.28Volume2.00 million shsAverage Volume3.11 million shsMarket Capitalization$17.81 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingSell Company Overview SeaStar Medical, Inc. (NASDAQ: ICU) is a medical device company focused on the development and commercialization of cerebral embolic protection systems for patients undergoing transcatheter aortic valve replacement (TAVR) procedures. The company’s mission is to reduce the risk of stroke and other neurologic events associated with structural heart interventions by capturing or deflecting embolic debris that can travel to the brain during catheter-based therapies. The company’s flagship product, TriGUARD® 3, is a next-generation embolic deflection device designed to provide coverage of all three cerebral vessels during TAVR. TriGUARD 3 features an advanced frame and filter design that conforms to varying patient anatomies, enabling physicians to position the device safely and effectively without obstructing critical arterial access routes. SeaStar Medical continues to invest in clinical trials and registry studies to demonstrate the safety and performance of its technology and to support regulatory clearances in North America, Europe and other key markets. Headquartered in Kansas City, Missouri, SeaStar Medical serves a global customer base through direct sales and distribution partnerships in Europe and parts of Asia Pacific, in addition to its U.S. operations. The company collaborates with interventional cardiologists, cardiac surgeons and research institutions to refine device design and expand indications. Its leadership team brings extensive experience from leading cardiovascular and medical device firms, guiding SeaStar Medical through product development, regulatory interactions and market introduction efforts to address the growing demand for neuroprotection in structural heart care.AI Generated. May Contain Errors. Read More SeaStar Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks12th Percentile Overall ScoreICU MarketRank™: SeaStar Medical scored higher than 12% of companies evaluated by MarketBeat, and ranked 916th out of 942 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for SeaStar Medical.Read more about SeaStar Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of SeaStar Medical is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of SeaStar Medical is -0.23, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about SeaStar Medical's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted16.21% of the float of SeaStar Medical has been sold short.Short Interest Ratio / Days to CoverSeaStar Medical has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in SeaStar Medical has recently increased by 42.81%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSeaStar Medical does not currently pay a dividend.Dividend GrowthSeaStar Medical does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted16.21% of the float of SeaStar Medical has been sold short.Short Interest Ratio / Days to CoverSeaStar Medical has a short interest ratio ("days to cover") of 0.6, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in SeaStar Medical has recently increased by 42.81%, indicating that investor sentiment is decreasing significantly. News and Social Media3.9 / 5News Sentiment0.95 News SentimentSeaStar Medical has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for SeaStar Medical this week, compared to 2 articles on an average week.Search Interest3 people have searched for ICU on MarketBeat in the last 30 days. MarketBeat Follows4 people have added SeaStar Medical to their MarketBeat watchlist in the last 30 days. This is an increase of 300% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, SeaStar Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $38,850.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.30% of the stock of SeaStar Medical is held by insiders.Percentage Held by InstitutionsOnly 1.69% of the stock of SeaStar Medical is held by institutions.Read more about SeaStar Medical's insider trading history. Receive ICU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for SeaStar Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ICU Stock News HeadlinesAnalyzing SeaStar Medical (NASDAQ:ICU) & Bausch + Lomb (NYSE:BLCO)October 15 at 2:15 AM | americanbankingnews.comSeaStar Medical announces preliminary results from SAVE Surveillance RegistrySeptember 30, 2025 | msn.com$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold stocks — in past bull markets, these plays delivered gains as high as 5,000% to 9,800%, and Sean has now identified five companies he believes could see explosive moves in the early stages of what may be the biggest gold rally yet.October 15 at 2:00 AM | Weiss Ratings (Ad)SeaStar Medical Restores Executive Salaries and FeesSeptember 29, 2025 | tipranks.comSeaStar Medical Reports Positive Early Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) at the 5th International Symposium on Acute Kidney Injury in ChildrenSeptember 29, 2025 | globenewswire.comICU Medical stock falls after SeaStar Medical trial enrollment increaseSeptember 25, 2025 | za.investing.comSeaStar Medical Stock Jumps On Safety Board Backing For Kidney Trial; Retail Eyes Another Run Despite After-Hours PlungeSeptember 25, 2025 | msn.comReview board recommends SeaStar Medical continue with NEUTRALIZE-AKI trialSeptember 24, 2025 | msn.comSee More Headlines ICU Stock Analysis - Frequently Asked Questions How have ICU shares performed this year? SeaStar Medical's stock was trading at $1.94 at the start of the year. Since then, ICU shares have decreased by 68.9% and is now trading at $0.6030. How were SeaStar Medical's earnings last quarter? SeaStar Medical Holding Corporation (NASDAQ:ICU) released its quarterly earnings results on Wednesday, August, 13th. The company reported ($0.18) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.43) by $0.25. The business had revenue of $0.34 million for the quarter, compared to the consensus estimate of $0.25 million. Read the conference call transcript. When did SeaStar Medical's stock split? Shares of SeaStar Medical reverse split on the morning of Monday, June 10th 2024.The 1-25 reverse split was announced on Monday, June 10th 2024. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 10th 2024. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. Who are SeaStar Medical's major shareholders? SeaStar Medical's top institutional shareholders include Trinity Financial Advisors LLC (0.18%). Insiders that own company stock include John Neuman, Kevin Chung, Heel Kenneth Van, Jennifer A Baird and Richard D Russell. View institutional ownership trends. How do I buy shares of SeaStar Medical? Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of SeaStar Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that SeaStar Medical investors own include Meta Platforms (META), Pfizer (PFE), Energy Transfer (ET), JPMorgan Chase & Co. (JPM), Kinder Morgan (KMI) and Visa (V). Company Calendar Last Earnings8/13/2025Today10/15/2025Next Earnings (Estimated)11/12/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Services Sub-IndustryMedical Equipment Current SymbolNASDAQ:ICU CIK1831868 Webseastarmedical.com Phone844-427-8100FaxN/AEmployees2Year FoundedN/AProfitability EPS (Trailing Twelve Months)($2.62) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$24.83 million Net Margins-1,915.27% Pretax Margin-1,914.88% Return on EquityN/A Return on Assets-232.65% Debt Debt-to-Equity RatioN/A Current Ratio1.52 Quick Ratio1.50 Sales & Book Value Annual Sales$766 thousand Price / Sales20.75 Cash FlowN/A Price / Cash FlowN/A Book Value($0.34) per share Price / Book-1.67Miscellaneous Outstanding Shares27,915,000Free Float27,552,000Market Cap$15.89 million OptionableNot Optionable Beta-1.07 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (NASDAQ:ICU) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredArizona-made nanochips the new millionaire maker?George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SeaStar Medical Holding Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share SeaStar Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.